Who invested in GlycanAge

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$8.7Mraised across 1 round since 2025, from 1 source

Latest round: Venture, $8.7MDec 2025
Investors: 4

See who backed them

The rounds

Dec 2025
Venture$8.7M
Source recorded

Funding filed with regulators

GlycanAge filed 5 raises, $13M in all. Filings say how much was sold and to how many investors; they never name the investors.

Apr 2026$748KUK share allotment
Oct 2025$1.8MUK share allotment
Aug 2025$4.3MUK share allotment
Jun 2025$2.1MUK share allotment
Jan 2024$3.8MUK share allotment

Founders and team

From GlycanAge's own website: 5 on the team.

Marko TarnajChief Product Officer
Martin IlievChief Financial Officer
Vladimira MihaylovaChief Marketing Officer
Zornitsa DimitrovaChief Operating Officer
Paula FrancekovićHead of Education

Everyone who backed them

Pareto HoldingsVC firm1round

Edward LandoAngel1round

LAUNCHub VenturesVC firm1round

Exceptional VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list GlycanAge as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.